Compare CZR & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CZR | PTCT |
|---|---|---|
| Founded | 1937 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 6.1B |
| IPO Year | 1989 | 2013 |
| Metric | CZR | PTCT |
|---|---|---|
| Price | $18.14 | $69.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 18 |
| Target Price | $32.14 | ★ $76.28 |
| AVG Volume (30 Days) | ★ 6.4M | 1.1M |
| Earning Date | 02-17-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 8.94 |
| Revenue | ★ $11,369,000,000.00 | $1,779,150,000.00 |
| Revenue This Year | $2.92 | $132.16 |
| Revenue Next Year | $2.77 | N/A |
| P/E Ratio | ★ N/A | $7.77 |
| Revenue Growth | 0.87 | ★ 97.54 |
| 52 Week Low | $17.95 | $35.95 |
| 52 Week High | $40.00 | $87.50 |
| Indicator | CZR | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 29.48 | 37.18 |
| Support Level | $17.95 | $69.75 |
| Resistance Level | $21.09 | $76.99 |
| Average True Range (ATR) | 1.02 | 2.60 |
| MACD | -0.26 | -0.44 |
| Stochastic Oscillator | 9.66 | 13.85 |
Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (47% of the estimated 2025 EBITDAR before corporate expenses) and regional (49%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2024. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.